Testing effectiveness (Phase 2)Study completedNCT00513435
What this trial is testing
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+36 more
National Cancer Institute (NCI) 9